Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Ambulatory Surgical Center Market
5.1. COVID-19 Landscape: Ambulatory Surgical Center Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Ambulatory Surgical Center Market, By Modality
8.1. Ambulatory Surgical Center Market, by Modality, 2022-2030
8.1.1. Hospital-Based Ambulatory Surgical Center
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Radiation Therapy
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Hormone Therapy
8.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Ambulatory Surgical Center Market, By Surgery Type
9.1. Ambulatory Surgical Center Market, by Surgery Type, 2022-2030
9.1.1. Dental
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Otolaryngology
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Endoscopy
9.1.3.1. Market Revenue and Forecast (2017-2030)
9.1.4. Obstetrics / Gynecology
9.1.4.1. Market Revenue and Forecast (2017-2030)
9.1.5. Opthalmology
9.1.5.1. Market Revenue and Forecast (2017-2030)
9.1.6. Orthopedic
9.1.6.1. Market Revenue and Forecast (2017-2030)
9.1.7. Cardiovascular
9.1.7.1. Market Revenue and Forecast (2017-2030)
9.1.8. Neurology
9.1.8.1. Market Revenue and Forecast (2017-2030)
9.1.9. Plastic Surgery
9.1.9.1. Market Revenue and Forecast (2017-2030)
9.1.10. Podiatry
9.1.10.1. Market Revenue and Forecast (2017-2030)
9.1.11. Others
9.1.11.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Ambulatory Surgical Center Market, By Speciality Type
10.1. Ambulatory Surgical Center Market, by Speciality Type, 2022-2030
10.1.1. Multi-specialty
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Single specialty
10.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Ambulatory Surgical Center Market, By Service
11.1. Ambulatory Surgical Center Market, by Service, 2022-2030
11.1.1. Diagnosis
11.1.1.1. Market Revenue and Forecast (2017-2030)
11.1.2. Treatment
11.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 12. Global Ambulatory Surgical Center Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Modality (2017-2030)
12.1.2. Market Revenue and Forecast, by Surgery Type (2017-2030)
12.1.3. Market Revenue and Forecast, by Speciality Type (2017-2030)
12.1.4. Market Revenue and Forecast, by Service (2017-2030)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Modality (2017-2030)
12.1.5.2. Market Revenue and Forecast, by Surgery Type (2017-2030)
12.1.5.3. Market Revenue and Forecast, by Speciality Type (2017-2030)
12.1.5.4. Market Revenue and Forecast, by Service (2017-2030)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Modality (2017-2030)
12.1.6.2. Market Revenue and Forecast, by Surgery Type (2017-2030)
12.1.6.3. Market Revenue and Forecast, by Speciality Type (2017-2030)
12.1.6.4. Market Revenue and Forecast, by Service (2017-2030)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Modality (2017-2030)
12.2.2. Market Revenue and Forecast, by Surgery Type (2017-2030)
12.2.3. Market Revenue and Forecast, by Speciality Type (2017-2030)
12.2.4. Market Revenue and Forecast, by Service (2017-2030)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Modality (2017-2030)
12.2.5.2. Market Revenue and Forecast, by Surgery Type (2017-2030)
12.2.5.3. Market Revenue and Forecast, by Speciality Type (2017-2030)
12.2.5.4. Market Revenue and Forecast, by Service (2017-2030)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Modality (2017-2030)
12.2.6.2. Market Revenue and Forecast, by Surgery Type (2017-2030)
12.2.6.3. Market Revenue and Forecast, by Speciality Type (2017-2030)
12.2.6.4. Market Revenue and Forecast, by Service (2017-2030)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Modality (2017-2030)
12.2.7.2. Market Revenue and Forecast, by Surgery Type (2017-2030)
12.2.7.3. Market Revenue and Forecast, by Speciality Type (2017-2030)
12.2.7.4. Market Revenue and Forecast, by Service (2017-2030)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Modality (2017-2030)
12.2.8.2. Market Revenue and Forecast, by Surgery Type (2017-2030)
12.2.8.3. Market Revenue and Forecast, by Speciality Type (2017-2030)
12.2.8.4. Market Revenue and Forecast, by Service (2017-2030)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Modality (2017-2030)
12.3.2. Market Revenue and Forecast, by Surgery Type (2017-2030)
12.3.3. Market Revenue and Forecast, by Speciality Type (2017-2030)
12.3.4. Market Revenue and Forecast, by Service (2017-2030)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Modality (2017-2030)
12.3.5.2. Market Revenue and Forecast, by Surgery Type (2017-2030)
12.3.5.3. Market Revenue and Forecast, by Speciality Type (2017-2030)
12.3.5.4. Market Revenue and Forecast, by Service (2017-2030)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Modality (2017-2030)
12.3.6.2. Market Revenue and Forecast, by Surgery Type (2017-2030)
12.3.6.3. Market Revenue and Forecast, by Speciality Type (2017-2030)
12.3.6.4. Market Revenue and Forecast, by Service (2017-2030)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Modality (2017-2030)
12.3.7.2. Market Revenue and Forecast, by Surgery Type (2017-2030)
12.3.7.3. Market Revenue and Forecast, by Speciality Type (2017-2030)
12.3.7.4. Market Revenue and Forecast, by Service (2017-2030)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Modality (2017-2030)
12.3.8.2. Market Revenue and Forecast, by Surgery Type (2017-2030)
12.3.8.3. Market Revenue and Forecast, by Speciality Type (2017-2030)
12.3.8.4. Market Revenue and Forecast, by Service (2017-2030)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Modality (2017-2030)
12.4.2. Market Revenue and Forecast, by Surgery Type (2017-2030)
12.4.3. Market Revenue and Forecast, by Speciality Type (2017-2030)
12.4.4. Market Revenue and Forecast, by Service (2017-2030)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Modality (2017-2030)
12.4.5.2. Market Revenue and Forecast, by Surgery Type (2017-2030)
12.4.5.3. Market Revenue and Forecast, by Speciality Type (2017-2030)
12.4.5.4. Market Revenue and Forecast, by Service (2017-2030)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Modality (2017-2030)
12.4.6.2. Market Revenue and Forecast, by Surgery Type (2017-2030)
12.4.6.3. Market Revenue and Forecast, by Speciality Type (2017-2030)
12.4.6.4. Market Revenue and Forecast, by Service (2017-2030)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Modality (2017-2030)
12.4.7.2. Market Revenue and Forecast, by Surgery Type (2017-2030)
12.4.7.3. Market Revenue and Forecast, by Speciality Type (2017-2030)
12.4.7.4. Market Revenue and Forecast, by Service (2017-2030)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Modality (2017-2030)
12.4.8.2. Market Revenue and Forecast, by Surgery Type (2017-2030)
12.4.8.3. Market Revenue and Forecast, by Speciality Type (2017-2030)
12.4.8.4. Market Revenue and Forecast, by Service (2017-2030)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Modality (2017-2030)
12.5.2. Market Revenue and Forecast, by Surgery Type (2017-2030)
12.5.3. Market Revenue and Forecast, by Speciality Type (2017-2030)
12.5.4. Market Revenue and Forecast, by Service (2017-2030)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Modality (2017-2030)
12.5.5.2. Market Revenue and Forecast, by Surgery Type (2017-2030)
12.5.5.3. Market Revenue and Forecast, by Speciality Type (2017-2030)
12.5.5.4. Market Revenue and Forecast, by Service (2017-2030)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Modality (2017-2030)
12.5.6.2. Market Revenue and Forecast, by Surgery Type (2017-2030)
12.5.6.3. Market Revenue and Forecast, by Speciality Type (2017-2030)
12.5.6.4. Market Revenue and Forecast, by Service (2017-2030)
Chapter 13. Company Profiles
13.1. Cerner Corporation
13.1.1. Company Overview
13.1.2. Modality Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Allscripts Healthcare Solutions Inc.
13.2.1. Company Overview
13.2.2. Modality Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. McKesson Corporation
13.3.1. Company Overview
13.3.2. Modality Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. McKesson Corporation
13.4.1. Company Overview
13.4.2. Modality Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Advanced Data Systems Corporation
13.5.1. Company Overview
13.5.2. Modality Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Surgical Information Systems
13.6.1. Company Overview
13.6.2. Modality Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. NextGen Healthcare
13.7.1. Company Overview
13.7.2. Modality Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Philips Healthcare
13.8.1. Company Overview
13.8.2. Modality Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Epic Systems Corporation
13.9.1. Company Overview
13.9.2. Modality Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. GE Healthcare
13.10.1. Company Overview
13.10.2. Modality Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become an Precedence Research client